Hyperfine (HYPR)
Makes and supports Swoop, a portable ultra-low-field brain-MRI system.
Something off on this page? Send us feedback.
Swoop combines portable ultra-low-field MRI hardware, Optive AI image-reconstruction software, and field service for brain imaging. It is Hyperfine's sole reportable business, sold through a direct organization focused on U.S. hospitals and neurology settings.
Founded in 2014, the company now centers its operations entirely on Swoop, a portable ultra-low-field MR system for brain imaging. It produces, supplies, services, and commercializes the system as its sole reportable business.
Next-generation Swoop hardware pairs with Optive AI image-reconstruction software. FDA clearance covers brain imaging across patients of all ages, following its initial U.S. brain-imaging clearance.
Commercialization initially focused on U.S. hospital and hospital-system contracts, then extended to emergency departments, hospital-based neurology clinics, and neurology offices. A direct sales and field-support organization supports the commercial single-system platform across these care settings.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 20, 2026 | BTIG | Reiterate | Rating: —Target: — | Target: $2 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $43.5M · Total debt $13.4M · Total assets $63.0M · Shareholders' equity $36.8M
- Revenue
- $3.9M
- Operating income
- −$8.5M
- Net income
- −$9.3M
No dividends on record.
| Institutions | 20.73% | 21.98M shares | |
|---|---|---|---|
| 85 holders · as of Jun 30, 2026 | |||
| Insiders | 1.94% | 2.05M shares | |
| 3 holders · as of Aug 25, 2026 | |||
| Other | 77.33% | 82.01M shares | |
| remainder | |||
106.05M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (106.05M in the company's Sep 22, 2026 report, 84.22M elsewhere); stakes use the report.
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 4.41% | 4.67M A | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 3.19% | 3.38M A | as of Jun 30, 2026 |
Geode Capital Management, LLCInstitution | 1.85% | 1.96M A | as of Jun 30, 2026 |
Fosun International LtdInstitution | 1.64% | 1.74M A | as of Jun 30, 2026 |
Catalio Capital Management, LPInstitution | 1.24% | 1.32M A | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 24, 2026 | Brett Hale | officer: CFO and CAO | −7,345 | $0.8540 |
| Aug 24, 2026 | Thomas Teisseyre | officer: Chief Operating Officer | −7,345 | $0.8540 |
| May 26, 2026 | Thomas Teisseyre | officer: Chief Operating Officer | −6,047 | $1.65 |
| May 26, 2026 | Brett Hale | officer: CFO and CAO | −6,047 | $1.65 |
| Mar 23, 2026 | Brett Hale | officer: CFO and CAO | −24,188 | $1.21 |
- GE HealthCare
Hospital MRI scanners and AI workflow overlap in brain imaging
- Philips (ADR)
BlueSeal MRI and AI workflow overlap in hospital brain imaging
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Hyperfine | $0.7701 | −1.41% | $65.8M | — | — | 4.0 | +44.8% |
| GE HealthCare | $66.35 | +2.38% | $29.27B | 18.8 | 12.8 | 1.4 | +5.8% |
| Philips (ADR) | $24.93 | +0.12% | $24.34B | 18.7 | 12.9 | 1.2 | −2.8% |
| Median | 18.8 | 12.9 | 1.3 | +1.5% |